drugset / Trial / NCT01845558

Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise

NCT01845558 ↗

Phase 4 Completed 69 enrolled Mucos Pharma GmbH & Co. KG
RandomizedCrossoverQuadruple-blindTreatment

Summary

The aim of the current study is to investigate the therapeutic effect and especially the mode of action of Wobenzym® plus, an anti-inflammatory drug containing proteolytic enzymes, on exercise induced muscle damage (eiMD) and recovery time in male amateur sportsmen with medium proficiency level compared to placebo.

Timeline

Start
2013-02
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Wobenzym® plus Protein / enzyme biologic — Oral

Indications

No indication recorded.